Optimising the quality and effectiveness of risk: benefit appraisal methodologies utilised in randomised control trials
<p>This investigation systematically assesses the quality and effectiveness of risk:benefit appraisal methodologies implemented in the analysis of published randomised controlled trials for pre-licensure biomedical innovations – therapeutics, devices and surgical procedures. The key finding is...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Thesis |
Language: | English |
Published: |
2015
|
Subjects: |
_version_ | 1826316349259907072 |
---|---|
author | Brindley, D David A. Brindley |
author2 | Carr, A |
author_facet | Carr, A Brindley, D David A. Brindley |
author_sort | Brindley, D |
collection | OXFORD |
description | <p>This investigation systematically assesses the quality and effectiveness of risk:benefit appraisal methodologies implemented in the analysis of published randomised controlled trials for pre-licensure biomedical innovations – therapeutics, devices and surgical procedures. The key finding is that, to date, reported applications of risk:benefit methodologies are highly heterogeneous and poorly reflective of the stakeholder needs assessed in the investigation.</p> <p>[Abstract continues in thesis]</p> |
first_indexed | 2024-03-06T20:59:02Z |
format | Thesis |
id | oxford-uuid:3a3f837c-1180-4609-80e5-c9d3d6ee1844 |
institution | University of Oxford |
language | English |
last_indexed | 2024-12-09T03:43:35Z |
publishDate | 2015 |
record_format | dspace |
spelling | oxford-uuid:3a3f837c-1180-4609-80e5-c9d3d6ee18442024-12-07T14:44:44ZOptimising the quality and effectiveness of risk: benefit appraisal methodologies utilised in randomised control trialsThesishttp://purl.org/coar/resource_type/c_db06uuid:3a3f837c-1180-4609-80e5-c9d3d6ee1844Organisation and evaluation of medical careEnglishOxford University Research Archive - Valet2015Brindley, DDavid A. BrindleyCarr, ABell, J<p>This investigation systematically assesses the quality and effectiveness of risk:benefit appraisal methodologies implemented in the analysis of published randomised controlled trials for pre-licensure biomedical innovations – therapeutics, devices and surgical procedures. The key finding is that, to date, reported applications of risk:benefit methodologies are highly heterogeneous and poorly reflective of the stakeholder needs assessed in the investigation.</p> <p>[Abstract continues in thesis]</p> |
spellingShingle | Organisation and evaluation of medical care Brindley, D David A. Brindley Optimising the quality and effectiveness of risk: benefit appraisal methodologies utilised in randomised control trials |
title | Optimising the quality and effectiveness of risk: benefit appraisal methodologies utilised in randomised control trials |
title_full | Optimising the quality and effectiveness of risk: benefit appraisal methodologies utilised in randomised control trials |
title_fullStr | Optimising the quality and effectiveness of risk: benefit appraisal methodologies utilised in randomised control trials |
title_full_unstemmed | Optimising the quality and effectiveness of risk: benefit appraisal methodologies utilised in randomised control trials |
title_short | Optimising the quality and effectiveness of risk: benefit appraisal methodologies utilised in randomised control trials |
title_sort | optimising the quality and effectiveness of risk benefit appraisal methodologies utilised in randomised control trials |
topic | Organisation and evaluation of medical care |
work_keys_str_mv | AT brindleyd optimisingthequalityandeffectivenessofriskbenefitappraisalmethodologiesutilisedinrandomisedcontroltrials AT davidabrindley optimisingthequalityandeffectivenessofriskbenefitappraisalmethodologiesutilisedinrandomisedcontroltrials |